Though the earnings cycle is winding down, Palantir PLTR, General Motors GM, and Bloom Energy BE have been nice standouts so far in the Q2 earnings season, all raising guidance.
Guidance upgrades are generally one of the most bullish things to watch for in earnings season, as renewed outlooks can often lead to positive EPS revisions, one of the strongest drivers of a stock’s near-term movement.
General Motors Earnings
General Motors posted a double-beat relative to our consensus expectations, with adjusted EPS of $3.57 reflecting a positive surprise of 14%. Sales of $48.0 billion came in 3% above our consensus sales estimate. The company raised its full-year 2026 EBIT adjusted guidance for the second time this year, with adjusted EPS guidance also getting raised.
EPS revisions for its current fiscal year got a boost from the lifted outlook, with the trend overall remaining positive for the entire last year. The profitability picture of automotive players is always a key driver behind sentiment, and the updated guidance across key profitability metrics remains a huge positive for GM’s share momentum overall.
Palantir Earnings
Palantir’s overall revenue surged by 93% YoY to $1.94 billion, yet again reflecting another acceleration relative to recent periods. Huge top-line growth has been led by rock-solid demand, with Palantir closing $3.4 billion of total contract value throughout the period, jumping 49% YoY.
The company lifted its guidance across many metrics, now expecting FY26 revenue in a band of $8.150 - $8.158 billion, reflective of 82% YoY growth. U.S. commercial demand is also expected to remain red-hot, with PLTR upping the guidance to reflect 134% YoY growth. The stock is a Zacks Rank #2 (Buy).
Bloom Energy Earnings
Bloom Energy delivered rock-solid results in its earnings release, easily beating our consensus expectations. The company posted record quarterly revenue of $1.07 billion, growing 166% year-over-year while also significantly raising its full-year 2026 outlook.
The growth surge was driven by soaring demand for its solid-oxide fuel cell systems thanks to major U.S. hyperscalers and AI data center operators seeking reliable on-site power.
Bloom Energy now expects full-year revenue in a range of $3.9 - $4.2 billion, with positive revisions also flowing in for its next fiscal year following the release. The stock sports a Zacks Rank #1 (Strong Buy), with EPS revisions also remaining on a bullish trajectory across the board.
Bottom Line
Guidance upgrades are always a bullish development to watch for in earnings releases, commonly leading to positive post-earnings share reactions. While it isn’t a guarantee that a stock will pop just because it raised its outlook, it remains a favorable fundamental factor. Companies raising guidance, particularly on the earnings front, always deserve some level of attention from investors.
All three stocks above – Palantir PLTR, General Motors GM, and Bloom Energy BE – have recently upped their outlooks.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
General Motors Company (GM): Free Stock Analysis Report
Bloom Energy Corporation (BE): Free Stock Analysis Report
Palantir Technologies Inc. (PLTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research